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Abstract
Epigenetics is an essential mechanism to control gene expression and fundamental cellular
processes. DNA methylation in CpG-rich promoters correlates with gene silencing. Histone mod-
ification including histone acetylation and deacetylation determines the stability of the chromatin
structure. Condensed chromatin (heterochromatin), which has a higher-order histone-DNA struc-
ture, prevents the access of transcriptional activators to their target genes. The fundamental unit
of eukaryotic chromatin consists of 146 bp of DNA wrapped around a histone octamer. Posttrans-
lational modifications of the histone tail and the chromatin remodeling complex disrupt histone-
DNA contacts and induce nucleosome mobilization. Histone acetylation of specific lysine residues
in the histone tail plays a crucial role in epigenetic regulation. Histone acetylation is a dynamic
process regulated by the antagonistic actions of 2 families of enzymes - the histone acetyltrans-
ferases (HATs) and the histone deacetylases (HDACs). The balance between histone acetylation
and deacetylation serves as a key epigenetic mechanism for transcription factor-dependent gene
expression and the developmental process. We review emerging evidence that DNA methylation,
histone acetylation modified by HAT and/or HDAC, and transcription factor-associated molecules
contribute to a mechanism that can alter chromatin structure, gene expression, and cellular differ-
entiation during chondrogenesis.
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Epigenetics is an essential mechanism to control gene expression and fundamental cellular processes.  
DNA methylation in CpG-rich promoters correlates with gene silencing.  Histone modiﬁcation including 
histone acetylation and deacetylation determines the stability of the chromatin structure.  Condensed 
chromatin (heterochromatin),  which has a higher-order histone-DNA structure,  prevents the access of 
transcriptional activators to their target genes.  The fundamental unit of eukaryotic chromatin con-
sists of 146 bp of DNA wrapped around a histone octamer.  Posttranslational modiﬁcations of the his-
tone tail and the chromatin remodeling complex disrupt histone-DNA contacts and induce nucleosome 
mobilization.  Histone acetylation of speciﬁc lysine residues in the histone tail plays a crucial role in 
epigenetic regulation.  Histone acetylation is a dynamic process regulated by the antagonistic actions of 
2 families of enzymes - the histone acetyltransferases (HATs) and the histone deacetylases (HDACs).  
The balance between histone acetylation and deacetylation serves as a key epigenetic mechanism for 
transcription factor-dependent gene expression and the developmental process.  We review emerging 
evidence that DNA methylation,  histone acetylation modiﬁed by HAT and/or HDAC,  and transcrip-
tion factor-associated molecules contribute to a mechanism that can alter chromatin structure,  gene 
expression,  and cellular diﬀerentiation during chondrogenesis.
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unctional musculoskeletal systems depend on the 
coordinated development of cartilage,  bone,  
tendon,  ligament,  and muscle [1].  Genetic (DNA) 
codes play a key role in normal development and 
appropriate gene expression,  called “genetic regula-
tion”,  this sequential expression is interrupted or 
altered by genetic disorders.  Although tissue-derived 
mesenchymal stem cells (MSCs) contain the same 
genetic information,  each cell has a diﬀerent gene 
expression and speciﬁc cellular function.  The sequen-
tial diﬀerentiation of mesenchymal progenitors is 
tightly controlled by many transcriptional parameters.  
Tissue-speciﬁc transcription factors regulate the 
spatiotemporal gene expressions by associating with 
cis-acting elements such as promoters,  enhancers,  and 
silencers in the DNA sequences [2].  Transcriptional 
coactivators and corepressors also have important 
roles in transcriptional regulation.  Since the decade 
of the genome project,  “epigenetic regulation” (such as 
DNA methylation,  histone modiﬁcation,  and chromatin 
remodeling) has been highlighted.  Epigenetics (“epi” 
means “above”) is deﬁned as gene-regulating activity 
that does not involve changes in the underlying DNA 
code.  The fundamental unit of eukaryotic chromatin,  
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the nucleosome,  consists of 146 bp of genomic DNA 
wrapped around a histone octamer (2 sets each of H2A,  
H2B,  H3,  and H4 core histones) [3].  DNA methyla-
tion is not only essential for mammalian development 
but also is a major epigenetic mechanism [2,  4,  5].  
Histone modiﬁcation can alter the condensed chroma-
tin (heterochromatin) structure by inﬂuencing histone-
DNA and histone-histone contacts [6,  7].  In addition,  
the chromatin remodeling complex disrupts histone-
DNA contacts and induces nucleosome mobilization 
[8].  The epigenetic marking system “histone code”,  
which modiﬁes the synergistic or antagonistic eﬀects 
of chromatin-associated proteins on histone-packaged 
DNA,  is a critical mechanism to regulate the tran-
scriptional status of gene expression for coordinated 
development [9].
　 Chondrogenesis derived from mesenchymal conden-
sation is a dynamic process in endochondral bone for-
mation.  The sequential diﬀerentiation and maturation 
steps of chondrocytes are regulated by transcription 
factors and growth factors such as the Sry-type high 
mobility group box (Sox) genes,  the runt-related Runx 
genes,  and the transforming growth factor (TGF)-β 
superfamily [10-12].  Sox9,  which encodes a high 
mobility group DNA-binding domain,  has been identi-
ﬁed as a master transcription factor in chondrogene-
sis [13].  Mutations in the Sox9 gene underlie the 
congenital dwarﬁsm syndrome,  campomelic dysplasia 
[14].  Mouse chimeras using Sox9 (-/-) embryonic stem 
cells shows that Sox9 (-/-) cells are excluded from 
cartilage tissues and are unable to express chondro-
cyte-speciﬁc genes such as α1(II) collagen (Col2a1) 
[15].  In the genital ridge,  however,  Col2a1 is not 
expressed despite abundant Sox9 expression [16].  In 
addition,  Sox9 overexpression in chondrocytes pro-
duces a phenotype of dwarﬁsm [17].  These ﬁndings 
suggest that additional mechanisms cooperatively 
regulate the Sox9-dependent chondrogenesis.  The 
TGF-β superfamily is a multifunctional growth factor 
for many cellular processes such as proliferation,  dif-
ferentiation,  and apoptosis [18].  In chondrocyte dif-
ferentiation,  TGF-β stimulation is necessary for 
MSC-derived primary chondrogenesis [19].  On the 
other hand,  chondrocyte maturation is inhibited by 
TGF-β [20].  These conﬂicting eﬀects of TGF-β 
during chondrogenesis might depend on chromatin 
structure and/or the epigenetics of each diﬀerentiated 
stage.  Several pathways following the activation of 
TGF-β receptors such as Smad2,  Smad3,  and mito-
gen-activated protein kinase have been identiﬁed as key 
intracellular signals in response to TGF-β treatments 
[18,  21].  We have previously demonstrated that 
TGF-β-regulated Smad3 activates the Sox9-depend-
ent transcription on the chromatin structure [22].  
Smad3 also associates with other transcription fac-
tors,  such as the osteogenic inducer Runx2 and the 
myogenic factor MyoD,  and the coactivator p300,  
which has an intrinsic histone acetyltransferase (HAT) 
activity [23-25].  From these ﬁndings,  chondrogene-
sis is considerably regulated by the cross-talk among 
transcription factors,  growth factor signals,  histone 
modiﬁcation,  and chromatin structure.
　 Epigenetics is an essential mechanism to control 
gene expression and fundamental cellular processes 
such as proliferation and diﬀerentiation [26-28].  In 
this review,  we focus on epigenetic regulation during 
chondrogenic diﬀerentiation.
DNA Methylation
　 DNA methylation is an important epigenetic mecha-
nism for the stable silencing and appropriate mainte-
nance of gene expression [2-4].  DNA methylation in 
mammals occurs in the cytosine of the CpG nucleotide 
via DNA methyltransferases.  CpG islands,  regions 
with more than 500 bp and a G/C content larger than 
55ｵ,  are localized in the promoter of about 40ｵ of 
all mammalian genes and are normally maintained in 
nonmethylated forms [3,  29].  CpG-rich promoters of 
chondrogenic-related genes,  such as Sox9, Runx2, 
chondromodulin-I,  and ﬁbroblast growth factor receptor 3,  
are hypomethylated during synovium-derived chondro-
genesis [30].  In addition,  the demethylation status of 
the chondromodulin-I promoter is correlated with 
chondromodulin-I gene expression through the binding 
of Sp3 as a transcriptional activator [31].  The 
Col2a1 gene is also less methylated in chondrocytes 
than in ﬁbroblasts [32].  CpG methylation-based gene 
silencing of α1(X) collagen (Col10a1),  a hypertrophic 
marker for diﬀerentiated chondrocytes,  is consis-
tently established in cartilage tissues and articular 
chondrocytes.  However,  the demethylation of the 
Col10a1 promoter correlates with Col10a1 induction 
during MSC-derived chondrogenesis [33].  These 
reports suggest that the state of DNA methylation 
regulates chondrogenic gene expression and cellular 
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diﬀerentiation along with chondrogenesis (Fig.  1).  
The patterns of genomic methylation are also associ-
ated with several human diseases such as ATR-X,  
Fragile X,  and ICF syndromes [34].  DNA methyla-
tion is important in determining the gene expression 
pattern observed in osteoarthritic chondrocytes [35].  
On the other hand,  CpG methylation does not seem to 
have a central role in the switch of aggrecan promoter 
activity in articular chondrocytes [36].  Further 
investigations will be required to understand the 
relationship between DNA methylation and chondro-
cyte diﬀerentiation.
Histone Modiﬁcation
　 Posttranslational histone modiﬁcation including 
acetylation,  methylation,  phosphorylation,  ubiquit-
ination,  and ADP-ribosylation determines the stability 
and/or instability of the chromatin structure [7,  9].  
External to the histone fold domain,  approximately 
25ｵ of the core histone mass is contained within the 
histone tail domain [6].  Histone tails,  located at the 
N-termini of all histones and the C-terminus of H2A,  
are modiﬁed by many enzymes such as HAT,  histone 
deacetylase (HDAC),  and histone methyltransferase.  
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Fig. 1　 Epigenetic regulation in the balance between histone acetylation and deacetylation.  A,  Schematic representation of a con-
densed heterochromatic structure.  CpG islands are methylated in the promoter of the inactive (repressed) genes on chromatin.  DNA and 
deacetylated histone form a higher-order chromatin structure via stable histone tails.  In heterochromatic regions,  the transcription factor 
(TF) cannot either recognize or associate with its DNA-binding sequence.  The repressing molecule and signal (Repressor) favorably asso-
ciate with TF via the recruitment of corepressor HDAC; B,  Schematic model of accessible euchromatic environment.  TF,  the coactivator 
HAT,  and activating molecule (Activator) (e.g.  Sox9,  p300,  and Smad3/4 transcriptional complex) cooperatively induce histone acetyla-
tion.  The chromatin structure changes from an inactive to accessible form by histone acetylation.  In the relaxed euchromatin,  other tran-
scriptional complexes cooperatively enhance the transcription of the activated gene.  H,  histone; Ac,  acetylation; Met,  methylation.
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The N-termini of histone tails interact with DNA and 
protein in chromatin.  Furthermore,  histone tails are 
critical for the self-assembly of condensed chromatin 
ﬁbers into higher-order structures [6].  The degree of 
chromatin folding directly inﬂuences the activity of 
DNA in transcription,  replication,  and recombination 
[37].  Therefore,  histone acetylation of speciﬁc lysine 
residues in the histone tail plays a fundamental role in 
epigenetic transcriptional regulation (Fig.  1).
Histone Acetylation and HAT Coactivator
　 Recent biochemical and genetic studies have identi-
ﬁed several multisubunit HAT complexes such as 
coactivator p300 and its paralog CREB-binding pro-
tein,  the MYST family,  and GNAT superfamily 
members [37,  38].  The multifunctional coactivator 
p300 has an important role for gene expression and 
cellular diﬀerentiation.  p300 acts as a protein scaﬀold 
and a bridging factor for the assembly of the tran-
scriptional apparatus.  In addition,  the HAT activity 
of p300 has the potential to facilitate transcriptional 
activity by modulating the chromatin structure [39].  
In chondrogenesis,  p300 stimulates transcription fac-
tor-mediated chromatin disruption.  Coactivator p300 
directly associates with the master chondrogenic fac-
tor Sox9,  and activates Sox9-dependent transcription 
[40].  We have previously reported that Sox9-
dependent transactivation is induced by p300-mediated 
histone acetylation of chromatin [41].  In vitro tran-
scription and S1 nuclease assays have revealed that 
p300 potentiates Sox9-dependent transcription on a 
chromatinized DNA template and is associated with 
hyperacetylated histones [41].  In addition,  histone 
hyperacetylation using the HDAC inhibitor trichosta-
tin A (TSA) enhances Sox9-regulated cartilage matrix 
gene expressions (COL2A1 and aggrecan) in human 
chondrocytes [41].  HDAC inhibitors,  including TSA 
and FK228,  have the synergistic potential to induce 
Sox9 expression via enhanced recruitment of nuclear 
factor Y (NF-Y) to the proximal promoter of Sox9 
[42].  p300 also acts as a transcriptional coactivator 
of cartilage homeoprotein-1 (Cart1),  which is involved 
in skeletal development,  through direct interaction 
with Cart1.  Deletion and mutagenesis analyses have 
identiﬁed that the 131st lysine of Cart1 is acetylated 
by p300-HAT,  and that Cart1 acetylation is critical in 
the association with p300 as well as p300-dependent 
transactivation [43].  Gene activation of the cartilage 
oligomeric matrix protein (COMP),  encoding a noncol-
lagenous matrix protein expressed predominantly in 
cartilage,  is cooperatively regulated by Sox9,  Sox5,  
Sox6,  and p300 [44].  The COMP promoter contains 
a positive and negative regulatory element.  Sox9 
directly binds to the positive regulatory element and 
activates COMP expression by associating with p300 
[44].  On the other hand,  the leukemia/lymphoma-
related factor transcriptional repressor inhibits COMP 
gene expression by recruiting HDAC1 as a negative 
regulatory element of the COMP promoter [45].  Tat-
interactive protein-60 (Tip60) is a member of the 
MYST family involved in a wide range of regulatory 
functions in various organisms [38].  Coactivator 
Tip60,  which mainly acetylates H4,  increases Sox9/
Sox5-dependent Col2a1 transcription by associating 
with Sox9 on chromatin [46].  The basic helix-loop-
helix transcription factor,  Scleraxis,  and its partner,  
E47,  cooperatively stimulate Sox9-dependent tran-
scription through the formation of a transcriptional 
complex with p300 [47].  These ﬁndings suggest that 
coactivator-induced histone acetylation triggers the 
transcriptional activation of chondrogenic genes and 
has a fundamental role in epigenetic regulation during 
chondrogenesis.
Histone Deacetylation and HDAC Corepressor
　 Acetylation of lysine residues in histone tails neu-
tralizes their positive charge,  thereby relaxing the 
chromatin (euchromatin) structure.  This interferes 
with the generation of higher-order chromatin struc-
tures,  and increases the accessibility of transcription 
factors to their target genes [48].  Histone deacetyla-
tion induced by HDACs has a crucial role in chromatin 
compaction and transcriptional repression.  Therefore,  
the balance between histone acetylation and deacetyla-
tion serves as a key regulatory mechanism for gene 
expression,  developmental processes,  and disease 
states [49].  HDACs lack intrinsic DNA-binding 
activity and are recruited to target genes via their 
direct association with transcriptional activators and 
repressors,  as well as their incorporation into multi-
protein transcriptional complexes [48].  Mammalian 
genomes encode 11 HDAC proteins with a highly 
conserved deacetylase domain.  Recent analyses of 
HDAC knockout mice have revealed speciﬁc functions 
158 Acta Med.  Okayama　Vol.  64,  No.  3Furumatsu et al.
4
Acta Medica Okayama, Vol. 64 [2010], Iss. 3, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol64/iss3/1
of individual HDACs in development and disease [49].  
In chondrogenesis,  HDAC4 has a central role in 
skeletal development [50].  HDAC4,  which is 
expressed in prehypertrophic chondrocytes,  regulates 
chondrocyte hypertrophy and endochondral bone for-
mation by interacting with and inhibiting the activity 
of Runx2 [50].  HDAC4-null mice display premature 
ossiﬁcation of developing bone due to early induction 
of chondrocyte hypertrophy,  and die during the ﬁrst 
week of life owing to ectopic ossiﬁcation,  which pre-
vents the expansion of the rib cage and leads to an 
inability to breathe [50].  Adenoviral HDAC4 overex-
pression promotes synovial stem cell-derived chondro-
genesis but inhibits its hypertrophic diﬀerentiation 
[51].  In cultured chondrocytes,  total HDAC activity 
and Col2a1 expression decrease along with the dedif-
ferentiation in passaged chondrocytes,  but recover 
during the rediﬀerentiation in pellet-cultured chondro-
cytes [52].  This phenomenon seems to be caused by 
HDAC-mediated transcriptional suppression of Wnt-5a,  
which inhibits Col2a1 expression [52].  On the other 
hand,  transcription factor Snail inhibits the expres-
sion of the Col2a1 gene by associating with HDAC1 
and HDAC2 [53].  These reports suggest that histone 
deacetylation is complicatedly modiﬁed by transcrip-
tion factor-related HDACs.  The balance between 
histone acetylation and deacetylation is tightly regu-
lated by many transcriptional complexes during chon-
drogenic diﬀerentiation and maturation (Fig.  1).
Growth Factors and Epigenetics
　 Growth factors,  cytokines,  and nonproteinaceous 
chemical compounds including dexamethasone,  vitamin 
D3,  prostaglandin E2,  and ascorbic acid inﬂuence 
gene expression and cellular diﬀerentiation during 
chondrogenesis [54].  Intracellular signaling activated 
by the ligand-receptor complex also plays an important 
role in epigenetic regulation by modulating the asso-
ciation between transcription factors and coactiva-
tors/corepressors.  The TGF-β superfamily and its 
signal mediators are well-documented in the ﬁeld of 
chondrocyte diﬀerentiation,  maturation,  and degen-
eration [55].  TGF-β-regulated Smad3,  but not 
Smad2,  promotes MSC-derived primary chondrogen-
esis through the activation of Sox9 via p300 recruit-
ment [56].  Smad3 stabilizes the association between 
Sox9 and coactivator p300 by forming a transcrip-
tional apparatus with Sox9/p300 [56].  Phospho-
rylated Smad3/4,  Sox9,  and p300 cooperatively 
activate the Sox9-dependent transcription on a chro-
matinized DNA template [22].  Bone morphogenetic 
protein (BMP)-2,  a member of the TGF-β superfam-
ily,  stimulates Sox9 expression by increasing the 
association between NF-Y-p300 complex and Sox9 
promoter.  BMP-2 also induces histone hyperacetyla-
tion and methylation at the Sox9 gene on chromatin 
[57].  Chondrocyte terminal diﬀerentiation is stimu-
lated by the activation of BMP-regulated Smad1/5/8 
and inhibited by the TGF-β-regulated Smad2/3 path-
way [55].  Although the interaction between Smad1 
and Runx2 is essential for Runx2-dependent transcrip-
tion,  the Runx2-Smad3 complex inhibits the function 
of Runx2 [58].  The BMP-activated Smad1/4 complex 
associates with Nkx3.2,  expressed in the sclerotome 
and developing cartilage,  by facilitating the recruit-
ment of corepressor HDAC1 [59].  The studies cited 
demonstrate that the interaction between the tran-
scription factor and TGF-β/BMP-dependent Smad 
can result in either transcriptional activation or 
repression (Fig.  1).  The growth factor-regulated 
signal may have the potential to activate (or repress) 
target gene expression by stabilizing the association 
between the transcription factor and the coactivator 
(or corepressor).
Epigenetics in Chondrogenic Diﬀerentiation
　 Epigenetics plays an essential role in determining 
the course of cellular diﬀerentiation and gene expres-
sion modulation without disrupting genetic informa-
tion.  DNA methylation correlates with gene silencing 
during chondrogenesis.  Histone acetylation and 
deacetylation,  which mainly modulate a relaxed and/
or condensed chromatin structure,  are precisely regu-
lated by transcription factor-related complex forma-
tion with coactivator HATs and with corepressor 
HDACs,  respectively.  The “epigenetic code” main-
tains subconscious developmental memories in chon-
drogenic diﬀerentiation [60,  61].
Acknowledgments.　We thank Dr. Hiroshi Asahara for his kind 
advice in preparing this review.  We are also grateful to our colleagues at 
the Department of Orthopaedic Surgery for their continuing support.
159Epigenetic Regulation in ChondrogenesisJune 2010
5
Furumatsu and Ozaki: Epigenetic Regulation in Chondrogenesis
Produced by The Berkeley Electronic Press, 2010
References
 1. Kragl M,  Knapp D,  Nacu E,  Khattak S,  Maden M,  Epperlein HH 
and Tanaka EM: Cells keep a memory of their tissue origin during 
axolotl limb regeneration.  Nature (2009) 460: 60-65.
 2. Jones PA and Takai D: The role of DNA methylation in mamma-
lian epigenetics.  Science (2001) 293: 1068-1070.
 3. Quina AS,  Buschbeck M and Di Croce L: Chromatin structure and 
epigenetics.  Biochem Pharmacol (2006) 72: 1563-1569.
 4. Reik W,  Dean W and Walter J: Epigenetic reprogramming in mam-
malian development.  Science (2001) 293: 1089-1093.
 5. Okano M,  Bell DW,  Haber DA and Li E: DNA methyltransferases 
Dnmt3a and Dnmt3b are essential for de novo methylation and 
mammalian development.  Cell (1999) 99: 247-257.
 6. Wolﬀe AP and Hayes JJ: Chromatin disruption and modiﬁcation.  
Nucleic Acids Res (1999) 27: 711-720.
 7. Strahl BD and Allis CD: The language of covalent histone modiﬁ-
cations.  Nature (2000) 403: 41-45.
 8. Ko M,  Sohn DH,  Chung H and Seong RH: Chromatin remodeling,  
development and disease.  Mutat Res (2008) 647: 59-67.
 9. Jenuwein T and Allis CD: Translating the histone code.  Science 
(2001) 293: 1074-1080.
10. Akiyama H,  Chaboissier MC,  Martin JF,  Schedl A and de 
Crombrugghe B: The transcription factor Sox9 has essential roles 
in successive steps of the chondrocyte diﬀerentiation pathway and 
is required for expression of Sox5 and Sox6.  Genes Dev (2002) 
16: 2813-2828.
11. Stricker S,  Fundele R,  Vortkamp A and Mundlos S: Role of Runx 
genes in chondrocyte diﬀerentiation.  Dev Biol (2002) 245: 95-108.
12. Shi Y and Massagué J: Mechanisms of TGF-β signaling from cell 
membrane to the nucleus.  Cell (2003) 113: 685-700.
13. Kamachi Y,  Uchikawa M and Kondoh H: Pairing SOX oﬀ: with 
partners in the regulation of embryonic development.  Trends Genet 
(2000) 16: 182-187.
14. Wagner T,  Wirth J,  Meyer J,  Zabel B,  Held M,  Zimmer J,  
Pasantes J,  Bricarelli FD,  Keutel J,  Hustert E,  Wolf U,  
Tommerup N,  Schempp W and Scherer G: Autosomal sex reversal 
and campomelic dysplasia are caused by mutations in and around 
the SRY-related gene SOX9.  Cell (1994) 79: 1111-1120.
15. Bi W,  Deng JM,  Zhang Z,  Behringer RR and de Crombrugghe B:  
Sox9 is required for cartilage formation.  Nat Genet (1999) 22: 85-
89.
16. Zhao Q,  Eberspaecher H,  Lefebvre V and de Crombrugghe B:  
Parallel expression of Sox9 and Col2a1 in cells undergoing chon-
drogenesis.  Dev Dyn (1997) 209: 377-386.
17. Akiyama H,  Lyons JP,  Mori-Akiyama Y,  Yang X,  Zhang R,  Zhang 
Z,  Deng JM,  Taketo MM,  Nakamura T,  Behringer RR,  McCrea 
PD and de Crombrugghe B: Interactions between Sox9 and β
-catenin control chondrocyte diﬀerentiation.  Genes Dev (2004) 18:  
1072-1087.
18. Liu F: Receptor-regulated Smads in TGF-β signaling.  Front Biosci 
(2003) 8: s1280-1303.
19. Pittenger MF,  Mackay AM,  Beck SC,  Jaiswal RK,  Douglas R,  
Mosca JD,  Moorman MA,  Simonetti DW,  Craig S and Marshak 
DR: Multilineage potential of adult human mesenchymal stem 
cells.  Science (1999) 284: 143-147.
20. Ferguson CM,  Schwarz EM,  Reynolds PR,  Puzas JE,  Rosier RN 
and OʼKeefe RJ: Smad2 and 3 mediate transforming growth factor-
β1-induced inhibition of chondrocyte maturation.  Endocrinology 
(2000) 141: 4728-4735.
21. Hanafusa H,  Ninomiya-Tsuji J,  Masuyama N,  Nishita M,  Fujisawa 
J,  Shibuya H,  Matsumoto K and Nishida E: Involvement of the 
p38 mitogen-activated protein kinase pathway in transforming 
growth factor-β-induced gene expression.  J Biol Chem (1999) 274:  
27161-27167.
22. Furumatsu T,  Ozaki T and Asahara H: Smad3 activates the Sox9-
dependent transcription on chromatin.  Int J Biochem Cell Biol 
(2009) 41: 1198-1204.
23. Alliston T,  Choy L,  Ducy P,  Karsenty G and Derynck R: TGF-β
-induced repression of CBFA1 by Smad3 decreases cbfa1 and 
osteocalcin expression and inhibits osteoblast diﬀerentiation.  
EMBO J (2001) 20: 2254-2272.
24. Liu D,  Black BL and Derynck R: TGF-β inhibits muscle diﬀerentia-
tion through functional repression of myogenic transcription factors 
by Smad3.  Genes Dev (2001) 15: 2950-2966.
25. Nishihara A,  Hanai JI,  Okamoto N,  Yanagisawa J,  Kato S,  
Miyazono K and Kawabata M: Role of p300,  a transcriptional 
coactivator,  in signalling of TGF-β.  Genes Cells (1998) 3: 613-
623.
26. Li E: Chromatin modiﬁcation and epigenetic reprogramming in 
mammalian development.  Nat Rev Genet (2002) 3: 662-673.
27. Jaenisch R and Bird A: Epigenetic regulation of gene expres-
sion: how the genome integrates intrinsic and environmental sig-
nals.  Nat Genet (2003) 33: Suppl.  245-254.
28. Felsenfeld G and Groudine M: Controlling the double helix.  Nature 
(2003) 421: 448-453.
29. Bird AP and Wolﬀe AP: Methylation-induced repression--belts,  
braces,  and chromatin.  Cell (1999) 99: 451-454.
30. Ezura Y,  Sekiya I,  Koga H,  Muneta T and Noda M: Methylation 
status of CpG islands in the promoter regions of signature genes 
during chondrogenesis of human synovium-derived mesenchymal 
stem cells.  Arthritis Rheum (2009) 60: 1416-1426.
31. Aoyama T,  Okamoto T,  Nagayama S,  Nishijo K,  Ishibe T,  Yasura 
K,  Nakayama T,  Nakamura T and Toguchida J: Methylation in the 
core-promoter region of the chondromodulin-I gene determines the 
cell-speciﬁc expression by regulating the binding of transcriptional 
activator Sp3.  J Biol Chem (2004) 279: 28789-28797.
32. Fernández MP,  Young MF and Sobel ME: Methylation of type II 
and type I collagen genes in diﬀerentiated and dediﬀerentiated 
chondrocytes.  J Biol Chem (1985) 260: 2374-2378.
33. Zimmermann P,  Boeuf S,  Dickhut A,  Boehmer S,  Olek S and 
Richter W: Correlation of COL10A1 induction during chondrogene-
sis of mesenchymal stem cells with demethylation of two CpG 
sites in the COL10A1 promoter.  Arthritis Rheum (2008) 58: 2743-
2753.
34. Egger G,  Liang G,  Aparicio A and Jones PA: Epigenetics in 
human disease and prospects for epigenetic therapy.  Nature (2004) 
429: 457-463.
35. Roach HI and Aigner T: DNA methylation in osteoarthritic chon-
drocytes: a new molecular target.  Osteoarthritis Cartilage (2007) 
15: 128-137.
36. Pöschl E,  Fidler A,  Schmidt B,  Kallipolitou A,  Schmid E and 
Aigner T: DNA methylation is not likely to be responsible for 
aggrecan down regulation in aged or osteoarthritic cartilage.  Ann 
Rheum Dis (2005) 64: 477-480.
37. Roth SY,  Denu JM and Allis CD: Histone acetyltransferases.  
Annu Rev Biochem (2001) 70: 81-120.
38. Sterner DE and Berger SL: Acetylation of histones and transcrip-
tion-related factors.  Microbiol Mol Biol Rev (2000) 64: 435-459.
39. Chan HM and La Thangue NB: p300/CBP proteins: HATs for 
transcriptional bridges and scaﬀolds.  J Cell Sci (2001) 114: 2363-
2373.
160 Acta Med.  Okayama　Vol.  64,  No.  3Furumatsu et al.
6
Acta Medica Okayama, Vol. 64 [2010], Iss. 3, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol64/iss3/1
40. Tsuda M,  Takahashi S,  Takahashi Y and Asahara H: Transcriptional 
co-activators CREB-binding protein and p300 regulate chondrocyte-
speciﬁc gene expression via association with Sox9.  J Biol Chem 
(2003) 278: 27224-27229.
41. Furumatsu T,  Tsuda M,  Yoshida K,  Taniguchi N,  Ito T,  
Hashimoto M,  Ito T and Asahara H: Sox9 and p300 cooperatively 
regulate chromatin-mediated transcription.  J Biol Chem (2005) 
280: 35203-35208.
42. Hanley KP,  Oakley F,  Sugden S,  Wilson DI,  Mann DA and 
Hanley NA: Ectopic SOX9 mediates extracellular matrix deposition 
characteristic of organ ﬁbrosis.  J Biol Chem (2008) 283: 14063-
14071.
43. Iioka T,  Furukawa K,  Yamaguchi A,  Shindo H,  Yamashita S and 
Tsukazaki T: P300/CBP acts as a coactivator to cartilage homeo-
protein-1 (Cart1),  paired-like homeoprotein,  through acetylation of 
the conserved lysine residue adjacent to the homeodomain.  J 
Bone Miner Res (2003) 18: 1419-1429.
44. Liu CJ,  Zhang Y,  Xu K,  Parsons D,  Alfonso D and Di Cesare PE:  
Transcriptional activation of cartilage oligomeric matrix protein by 
Sox9,  Sox5,  and Sox6 transcription factors and CBP/p300 coacti-
vators.  Front Biosci (2007) 12: 3899-3910.
45. Liu CJ,  Prazak L,  Fajardo M,  Yu S,  Tyagi N and Di Cesare PE:  
Leukemia/lymphoma-related factor,  a POZ domain-containing 
transcriptional repressor,  interacts with histone deacetylase-1 and 
inhibits cartilage oligomeric matrix protein gene expression and 
chondrogenesis.  J Biol Chem (2004) 279: 47081-47091.
46. Hattori T,  Coustry F,  Stephens S,  Eberspaecher H,  Takigawa M,  
Yasuda H and de Crombrugghe B.  Transcriptional regulation of 
chondrogenesis by coactivator Tip60 via chromatin association 
with Sox9 and Sox5.  Nucleic Acids Res (2008) 36: 3011-3024.
47. Furumatsu T,  Shukunami C,  Amemiya-Kudo M,  Shimano H and 
Ozaki T: Scleraxis and E47 cooperatively regulate the Sox9-
dependent transcription.  Int J Biochem Cell Biol (2010) 42: 148-
156.
48. Shahbazian MD and Grunstein M: Functions of site-speciﬁc his-
tone acetylation and deacetylation.  Annu Rev Biochem (2007) 
76: 75-100.
49. Haberland M,  Montgomery RL and Olson EN: The many roles of 
histone deacetylases in development and physiology: implications 
for disease and therapy.  Nat Rev Genet (2009) 10: 32-42.
50. Vega RB,  Matsuda K,  Oh J,  Barbosa AC,  Yang X,  Meadows E,  
McAnally J,  Pomajzl C,  Shelton JM,  Richardson JA,  Karsenty G 
and Olson EN: Histone deacetylase 4 controls chondrocyte hyper-
trophy during skeletogenesis.  Cell (2004) 119: 555-566.
51. Pei M,  Chen D,  Li J and Wei L: Histone deacetylase 4 promotes 
TGF-β1-induced synovium-derived stem cell chondrogenesis but 
inhibits chondrogenically diﬀerentiated stem cell hypertrophy.  Dif-
ferentiation (2009) 78: 260-268.
52. Huh YH,  Ryu JH and Chun JS: Regulation of type II collagen 
expression by histone deacetylase in articular chondrocytes.  J Biol 
Chem (2007) 282: 17123-17131.
53. Hong S,  Derfoul A,  Pereira-Mouries L and Hall DJ: A novel 
domain in histone deacetylase 1 and 2 mediates repression of car-
tilage-speciﬁc genes in human chondrocytes.  FASEB J (2009) 23:  
3539-3552.
54. Heng BC,  Cao T and Lee EH: Directing stem cell diﬀerentiation 
into the chondrogenic lineage in vitro.  Stem Cells (2004) 22:  
1152-1167.
55. van der Kraan PM,  Blaney Davidson EN,  Blom A and van den 
Berg WB: TGF-beta signaling in chondrocyte terminal diﬀerentia-
tion and osteoarthritis: modulation and integration of signaling 
pathways through receptor-Smads.  Osteoarthritis Cartilage (2009) 
17: 1539-1545.
56. Furumatsu T,  Tsuda M,  Taniguchi N,  Tajima Y and Asahara H:  
Smad3 induces chondrogenesis through the activation of SOX9 via 
CREB-binding protein/p300 recruitment.  J Biol Chem (2005) 280:  
8343-8350.
57. Pan Q,  Wu Y,  Lin T,  Yao H,  Yang Z,  Gao G,  Song E and Shen H:  
Bone morphogenetic protein-2 induces chromatin remodeling and 
modiﬁcation at the proximal promoter of Sox9 gene.  Biochem 
Biophys Res Commun (2009) 379: 356-361.
58. Kang JS,  Alliston T,  Delston R and Derynck R: Repression of 
Runx2 function by TGF-β through recruitment of class II histone 
deacetylases by Smad3.  EMBO J (2005) 24: 2543-2555.
59. Kim DW and Lassar AB: Smad-dependent recruitment of a histone 
deacetylase/Sin3A complex modulates the bone morphogenetic 
protein-dependent transcriptional repressor activity of Nkx3.2.  Mol 
Cell Biol (2003) 23: 8704-8717.
60. Furumatsu T: Sox9-dependent transcription in chondrogenesis.  J 
Joint Surg (2008) 27: 146-147 (in Japanese).
61. Furumatsu T: Sox9-related epigenetic regulation.  Orthop Surg 
Trauma (2009) 52: 1040-1041 (in Japanese).
161Epigenetic Regulation in ChondrogenesisJune 2010
7
Furumatsu and Ozaki: Epigenetic Regulation in Chondrogenesis
Produced by The Berkeley Electronic Press, 2010
